IGF-1 LR3 1 mg (USA domestic)

IGF-1 LR3 1 mg by ZPHC is supplied as a set of five individual lyophilized vials, each containing 0.2 mg of IGF-1 LR3, for a total peptide content of 1 mg.

IGF-1 LR3, also known as Long R3 IGF-1, is a modified analog of insulin-like growth factor 1 developed for laboratory research involving IGF signaling, receptor activity, and related cellular pathways.

What Is Included IGF-1 LR3 1 mg by ZPHC?

Each IGF-1 LR3 1 mg package contains:

• 5 vials × 0.2 mg IGF-1 LR3
• 1 mg total peptide content
• Lyophilized peptide format
• ZPHC-branded packaging
• USA Domestic product configuration
• Verifiable on https://zphc.com/

What Is IGF-1 LR3?

IGF-1 LR3 is a modified version of insulin-like growth factor 1. It consists of 83 amino acids and differs structurally from native IGF-1 through two primary modifications: an arginine substitution at position 3 and an additional 13-amino-acid sequence at the N-terminus.

These structural changes were designed to alter the peptide’s interaction with IGF-binding proteins, which is one reason IGF-1 LR3 is frequently used in laboratory studies examining IGF-related signaling.

IGF-1 LR3 vs Native IGF-1

Although IGF-1 LR3 is derived from the IGF-1 structure, the two should not be considered identical compounds.

Native IGF-1 consists of 70 amino acids, while Long R3 IGF-1 contains 83 amino acids as a result of its extended N-terminal sequence. The Arg3 modification also changes its interaction with IGF-binding proteins.

Because of these differences, IGF-1 LR3 is commonly studied as a separate research compound rather than as a direct equivalent of naturally occurring IGF-1.

Research Interest

IGF-1 LR3 is primarily investigated in laboratory settings involving:

• IGF-1 receptor signaling
• Cellular growth and differentiation pathways
• IGF-binding protein interactions
• Metabolic signaling
• Comparative studies of IGF-1 analogs
• Protein and peptide signaling research

Research findings involving IGF-1 LR3 should not be interpreted as established therapeutic effects in humans.

ZPHC IGF-1 LR3 Five-Vial 1 mg Format

This ZPHC product provides 1 mg of IGF-1 LR3 divided across five 0.2 mg vials rather than supplied in a single vial.

The individual-vial configuration makes it straightforward to identify the amount of research material contained in each sealed unit while keeping unused material separately packaged.

Product specifications:

• Compound: IGF-1 LR3 / Long R3 IGF-1
• Brand: ZPHC
• Total amount: 1 mg
• Vial quantity: 5
• Amount per vial: 0.2 mg
• Form: Lyophilized peptide
• Sequence length: 83 amino acids
• Shipping designation: USA Domestic

ZPHC IGF-1 LR3 Product Verification

The product is supplied as a ZPHC IGF-1 LR3 preparation. Packaging and authentication information can be checked through the manufacturer’s official verification resources.

Customers should always inspect packaging, batch information, and available authenticity features when receiving the product.

IGF-1 LR3 1 mg USA Domestic

This listing is for the IGF-1 LR3 1 mg USA Domestic version offered by SparksHealth. The complete package contains five individually packaged 0.2 mg vials, providing 1 mg of IGF-1 LR3 in total.

IGF-1 LR3 is an investigational research compound and is not an approved medication for the diagnosis, treatment, cure, or prevention of disease. Product information is provided for research and educational reference purposes and should not be interpreted as medical advice.